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Background: Group B streptococcus (GBS) has been implicated in adverse pregnancy outcomes. GBS recto-vaginal
colonization rates significantly vary among different communities and geographic locations. Limited data is available
on the prevalence and effects of GBS recto-vaginal colonization among pregnant mothers in developing countries
like Ethiopia.
Objective: To assess the prevalence of GBS recto-vaginal colonization among near term pregnant mothers and the
antimicrobial susceptibility pattern of the isolates.
Methods: A cross sectional descriptive study was conducted on pregnant mothers at gestational age of 35–37 weeks
attending Ante Natal Clinics at Ghandi Memorial (GMH) and Tikur Anbessa Specialized Hospital (TASH) in Addis Ababa.
Samples from lower genital tract and rectum were collected and cultured for GBS on CHROM agar Strep B.
Results: Twenty two of the 300 pregnant mothers (7.2%) studied were found to have positive GBS recto-vaginal
culture. Twelve isolates (55%) were sensitive to penicillin while 20 (91%) were sensitive to ampicilline. All isolates
except one were sensitive to Erythromycin.
Conclusion: The study showed recto-vaginal GBS colonization among near term pregnant mothers is reasonably high
in our community calling for the need to screen mothers near term and provide appropriate antimicrobial prophylaxis
to prevent potential adverse maternal and neonatal outcome.
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Pregnant women colonized by Group B Streptococcus
(GBS) are known to be at an increased risk of adverse
obstetric outcomes. GBS is also known to infect the
newborn and hence increase the neonatal morbidity and
mortality [1-3]. Epidemiological studies have revealed
that pregnant women colonized with GBS are 25 times
more likely to deliver infants with early onset GBS dis-
ease than women with negative prenatal cultures [4,5].
Chemoprophylaxis remains the most effective means
to prevent maternal and neonatal infections. Penicillin,* Correspondence: siteet@yahoo.com
1Department of Gynecology and Obstetrics, Addis Ababa University, School
of Medicine, P.O. BOX: 27954/1000, AA, Addis Ababa, Ethiopia
Full list of author information is available at the end of the article
© 2014 Woldu et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.ampicillin, erythromycin and clindamycin are drugs of
choice for antibiotic prophylaxis against GBS. However
reports of emerging resistance to theses drugs have made
susceptibility study an important component of GBS con-
trol strategy. Rate for neonatal invasive disease both early
and late onset is between 1.7 and 3.3 per 1000 live births
in the USA and 0.2-0.6 per 1000 live births in Europe,
Canada and Israel [2,3]. Studies in USA showed case fatal-
ity rates for the early onset GBS disease to be 5 to 20% [6].
Infants born to heavily recto-vaginal GBS colonized
women were also at an increased risk of neonatal sep-
sis [6]. Although excellent data are available from the
developed world, there is little data on GBS recto-vaginal
colonization and associated maternal and neonatal com-
plications in developing countries.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Sciences in 1987, involving 200 postpartum women, and 80
newborn infants reported GBS recto-vaginal colonization
rate of 9% in postpartum women and GBS oro-pharyngeal
colonization rate of 5% in the newborn infants [7].
In a study conducted in Peru, Lima, the overall preva-
lence of recto-vaginal colonization of GBS was reported to
be 8%. GBS was isolated more frequently from the vaginal
than the rectum [8].
Rates of GBS colonization vary widely throughout the
globe. Culture methods, including the number and type
of sites cultured and type of medium used, have accounted
for some of this variations [8]. Despite the differences in
technique, real regional variation exists. High prevalence
rates have been reported from the United States (15-25%),
Jordan (30%) and Gambia (22%) [2,9,10]. One study in
Mexico City showed prevalence rate of 4% [11]. Low
prevalence rates have also been reported in Italy (6.6%)
and Turkey (8.7%) [12,13]. A report from Iran revealed
9.1% GBS colonization rate among pregnant mothers.
In addition to regional differences, some investigators
have also reported racial differences in GBS colonization
rates [14].
Similar studies done on pregnant women in Tanzania
and Malawi revealed a higher GBS colonization rate of
23% and 16.5% respectively [15,16].
The magnitude of the problem and its public health
importance was appreciated by academic institutions and
organizations and strategies to prevent related morbidities
and mortalities was launched. After reviewing scientific
data and collecting expert opinions, American College of
Obstetricians and Gynecologists (ACOG) and Centers for
Disease Control (CDC) in 1996 developed guideline on
prevention of perinatal GBS disease and that was revised
again in 2002 [17-19].
This study was designed to evaluate the prevalence of
recto-vaginal colonization of GBS in pregnant mothers near
term attending Ante Natal Clinics (ANC) in two teaching
Hospital in Addis Ababa, identify associated socio demo-
graphic and obstetric risk factors and assess the antimicro-
bial sensitivity pattern of the isolates.
Materials and methods
A cross sectional descriptive study was conducted on
pregnant mothers at gestational age of 35–37 weeks,
who were not taking any antibiotics, attending ANC at
Gandhi Memorial Hospital and Tikur Anbassa Specialized
Hospital for a period of three months in 2010. These hos-
pitals are referral hospitals providing comprehensive ante-
partum, intra-partum and post-partum care. Nearly 8000
mothers deliver in these hospitals annually.
A single proportion formula with a standard deviation,
Z of 1.96, a degree of precision f 0.05, was used to cal-
culate sample size. Sample size n = 300 was calculatedusing P = 9% from study done in Gondar, Ethiopia [7].
After the hospitals ethics board permission was ob-
tained, mothers who fulfilled the inclusion criteria and
who were willing to participate in the study were se-
lected by simple quota sampling technique until a total
of 300 mothers were recruited. Verbal consent was se-
cured after reading a written consent (because of low lit-
eracy rate) that was approved by the department of
obstetrics and gynecology research and publication com-
mittee and after explaining the objective of the study
and its potential benefits to the mothers and their neo-
nates. IRB: Addis Ababa University, college of health sci-
ences Institutional Review Board.
Data was collected through interview and review of
the ANC charts. Analysis was done using the SPSS stat
software. Samples from the upper vagina and rectum
were collected for each mother using sterile applicator
and were transported at room temperature using Amies
transport media. It was then inoculated on to CHROM
agar sterp B plate (made by Chroagar, Paris) within 1–6
hours of collection. The plates were incubated at 37 de-
gree Celsius for 24 hrs. After 24 hrs, only positive cul-
tures were analyzed and culture medias with no growth
were discarded. Isolates were identified based on colo-
nial morphology, catalase reaction, CAMP test and
strept B latex test (made by Remel, Canada). Antimicrobial
sensitivity to commonly used antibiotics like penicillin
(R < 11 mm, S > 22 mm), ampicillin (R < 20 mm, S > 29 mm),
erythromycin (R < 13 mm, S > 18 mm) and clindamycin
(R < 15 mm, S > 19 mm) was done by blood agar, using
agar diffusion test technique. Results of those mothers
with positive GBS culture were communicated to the
treating physician for prophylactic measures, as there is
no GBS prophylaxis protocol in place in Ethiopia.
Results
Twenty two (7.3%) among the 300 pregnant women
screened were colonized by S. aglactae. As shown on
Table 1, twenty mothers with GBS colonization positive
cultures are in the moderate income group while two
were in the lower income group. Eleven (50%) mothers
were primigravida while 8 (36.5%) had one and 3 (13.5%)
had two or more prior pregnancies. Culture for GBS was
positive in 10 mothers in the age range of 20 to 25 years,
in seven mothers 26 to 30 years, and three mothers 31
to 35 years while one was below 20 years and one above
36 years. In vitro antimicrobial susceptibility pattern of
GBS isolates is shown in Table 2.
Discussion
GBS colonization rate of 7.3% in term pregnancies seen in
this study is higher than 6.6% reported from Italy but
lower than many reports in the literature [2,9,12,13,15,16].
The reason for the varying results may be attributed to the
Table 1 Prevalence of recto vaginal GBS colonization and
socio-demographic characteristics, Addis Ababa, Ethiopia
2010
Recto vaginal GBS Culture positive Culture negative
N (%) N (%)
22 (7.3%) 278 (92.7%)
Age (Years)











Nulli para 11 91
One 8 122
Two or more 3 65
Total 22 278
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place. Other factors that may have contributed to this vari-
ation include socio-economic factors, variation in clinical
practices, method of sample collection and the techniques.
Besides, ethnic and genetic factors might play a role in
variation of the rates of infection with GBS [6]. In this
study maternal GBS colonization rate was seen more
among the primigravidae and second gravidas. This was
consistent with the findings in other studies [5]. It is also
suggested that this greater GBS colonization often ob-
served among the primigravidae and the second gravida
has epidemiological implications in terms of maternal
complications and neonatal infections and policy issues
for introducing preventive interventions [5,18].
However, the reason for this parity–specific group B
streptococcal susceptibility is not clearly understood.Table 2 GBS in vitro antimicrobial sensitivity pattern,
Addis Ababa, Ethiopia, 2010
Antimicrobial Sensitive Intermediate Resistant Total
N (%) N (%) N (%)
Clindamycin 19 1 2 22
Erythromycin 20 - 2 22
Ampicillin 20 1 1 22
Penicillin 12 2 8 22Overall, 86.5% of the women with GBS are primi-
gravida or nulliparas. This finding is consistent with
findings from another study that showed 88.9% of
women with positive GBS cultures to have three or fewer
pregnancies [7].
GBS colonization has significant correlation with the
risk of perinatal infection [8]. CDC in 1996 also found
that mothers who are carriers of GBS have 50% chance
of infecting their babies before or during birth [18]. The
finding of more positive isolates in lower parity in this
study indicate that infants born to the primigravida and
second gravida mothers, who are carrying GBS, may be
at risk of developing GBS neonatal disease. Of the GBS
positive cases studied, 77.3% were women of 20 to
30 years of age. This is expected as this is the age of in-
creased sexual activity and GBS organisms are known to
be sexually transmitted [4].
The GBS organisms isolated in this study showed
higher susceptibility to ampicillin and erythromycin
while significant number showed resistance to penicillin.
This finding differs from the study in Calabar, which
showed 100% sensitivity to penicillin [7]. This may be
due to the wide and non prescription use of penicillin in
our community because of weak drug control mechan-
ism. However the finding has significant clinical implica-
tion regarding the use of penicillin in the treatment of
GBS related infections both in mothers and their neo-
nates. Ampicillin has been preferred by numerous inves-
tigators as a drug of choice because of its safety during
pregnancy and its broader spectrum compared to
penicillin.
Though this study has limitations and weaknesses in
terms of small sample size, non probability quota sam-
pling method and neonates are not included in the study
to assess the neonatal infection rate compared to other
studies, the result of this study will help clinicians and
policy makers to understand the magnitude of the prob-
lem and plan a uniform protocol based on antibiotic
sensitivity pattern. The findings in this study indicate the
need for future large scale, preferably cohort, study in
Ethiopia.Conclusion and recommendation
The prevalence of GBS colonization seen among mothers
attending ANC at two referral hospitals in Addis Ababa,
Ethiopia, though is lower compared to other studies in
similar settings in Africa, indicates the need to screen
mothers near term and plan appropriate intervention. Fur-
ther large scale study to ascertain the prevalence of GBS
colonization among pregnant mothers at different gesta-
tional age and the effects on the outcome of pregnancy,
both maternal and neonatal should be conducted to intro-
duce national guideline.
Woldu et al. Reproductive Health 2014, 11:80 Page 4 of 4
http://www.reproductive-health-journal.com/content/11/1/80Competing interests
The authors declare that they do not have competing interests.
Authors' contributions
ZL was the one who initiated the research idea and selected this topic. She
drafted the proposal, secured small fund to purchase culture media and
transport media appropriate for Group B streptococcus. TT played a very
important role starting from receiving the samples brought to him from the
hospitals, doing the culture and all important microbiological studies. SW
was a focal person at one of the hospitals (GMH) where the sample was
collected, collected the samples and all the required data. Did the data
entry, analysis and final write up. MG was a focal person at one of the
hospitals (TASH) where the sample was collected, collected the samples and
all the required data. All authors read and approved the final manuscript.
Authors' information
ZW is an associate professor at Addis Ababa University, School of Medicine,
Department of Obstetrics and Gynecology. She is involved in teaching and
service de4livery at the Hospital. She was a Department head for three years
and also served as Dean of the School of Medicine for another three years.
TT is an active member of the medical laboratory technology at Addis
Ababa University, School of Medicine. He is involved in teaching and also
give service in the Hospital Laboratory.
SW is an assistant professor of Ob-Gy at Addis Ababa University, School of
Medicine. He is currently involved in teaching under graduates and post
graduates in the department. Was involved in several Obstetric and
gynecology research activities.
MG is an assistant professor of Ob-Gy at Addis Ababa University, School of
Medicine. She is currently involved in teaching under graduates and post
graduates in the department.
Acknowledgement
We would like to appreciate Addis Ababa University, School of Medicine for
covering the cost of culture and transport media from their limited budget.
We are also very grateful for Tikur Anbassa Specialized Hospital and Gandhi
Memorial Hospital for allowing us to access the study subjects and their
personal information. The support of Ob-Gy residents in both Hospital was
very important in identifying the study subjects and also treating those who
were found to be culture positive.
Author details
1Department of Gynecology and Obstetrics, Addis Ababa University, School
of Medicine, P.O. BOX: 27954/1000, AA, Addis Ababa, Ethiopia. 2Medical
Laboratory Technology, Addis Ababa University, School of Medicine Tikur
Anbessa Hospital, Addis Ababa, Ethiopia.
Received: 17 November 2013 Accepted: 29 November 2014
Published: 5 December 2014
References
1. Breed: Bergley’s Manual of Determinative Bacteriology. 7th edition. Baltimore:
The Williams and Wilkins Co; 1957:517–518.
2. Baker J, Edwards M: Group B Streptococcal Infection. In Infectious Disease
of the Fetus and Newborn Infant. Edited by Remington J, Klein JO.
Philadelphia: W.B Sounder Co; 1995:980–1054.
3. Alttoparlak U, Kadanali A, Kadanali S: Genital flora in pregnancy and its
association with group B streptococcal colonization. Int J Gynecol Obstet
2004, 87:245–248.
4. Schuchat A, Wenger J: Epidemiology of group B streptococcal disease:
Risk factors prevention strategy and vaccine development. Epidemiol Rev
1994, 16:374–402.
5. Schuchat A, Whitney C, Zangwill K: Prevention of prenatal group B
streptococcal disease; a public health perspective. Morbid Mortal Weekly
Rep 1996, 45(RR-7):1–24.
6. American academy of Pediatrics committee on infectious diseases and
committee on fetus and newborn. Revised guidelines for prevention of
early onset group B streptococcal (GBS) infection. Pediatrics 1997,
99:489–497.
7. Schmidt J, Halle H, Mohammed T, Gunther E: Colonization of pregnant
women and their newborn infants with Group B Streptococci in the
Gondar College of Medical Sciences. Ethiop Med J 1989, 27:115–119.8. Timothy C, Maritza C, Robert G, Aldo V, Patricia C: Group B Streptococcal
colonization in a developing country: its association with sexually
transmitted disease and socioeconomic factors. Am J Trop Med Hyg 1998,
59(4):634.
9. Sunna E, el-Daher N, Bustami K, Na’was T: A study of Group B Streptococcal
carrier state during late pregnancy. Trop Geogr Med 1991, 43:161–164.
10. Suara O, Adegbola A, Baker J, Secka O, Mulholland K, Greenwood M:
Carriage of Group B Streptococci in pregnant Gambian mothers and
their infants. J infect Dis 1994, 170:1316–1319.
11. De Lourdes M, Kretschmer R, Becker I, Guzman A, Gallardo L, Lepe M:
Colonization of Mexican pregnant women with Group B Streptococcus.
J Infect Dis 1981, 143:134.
12. Citernesi A, Formica G, Caruso S, Curiel P: Vaginal colonization of
streptococcus B in pregnancy. Minerva Ginecol 1996, 48:227–233.
13. Ayata A, Guvenc H, Felek S, Aygun D, Kosabay K, Bektas S: Maternal
carriage and neonatal colonization of Group B Streptococci in labor are
uncommon in Turkey. Pediatr Perinat Epidemiol 1994, 8:188–192.
14. Bahia J, Shahnaz P, Shahnoz P: The prevalence and adverse effects of
Group B Streptococcal colonization during pregnancy. Arch Iranian Med
2008, 11(6):654–657.
15. Agricola J, Mecky I, Furaha A, Eligius F: Maternal and neonatal colonisation
of group B streptococcus at Muhimbili National Hospital in Dar es
Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance.
BMC Public Health 2009, 9:437.
16. Drowela T, Komolafe O, Igbigbi A: Prevalence of group B Streptococcus
colonization in an antenatal women at Queen Elizabeth Central Hospital,
Blantyre-a preliminary study. Malawi Med J 2005, 17(3):97–99.
17. American College of Obstetricians and Gynecologists, Committee on Obstetric
Practice. Prevention of early-onset group B streptococcal disease in newborns
[Opinion 173]. Washington, D. C: American College of Obstetricians and
Gynecologists; 1996.
18. CDC: Prevention of perinatal group B streptococcal disease: a public
health perspective. MMWR 1996, 45(RR-7):1–24.
19. Prevention of perinatal group B streptococcal disease: a revised
guideline from CDC. MMWR 2002, 51(RR-51):1–18.
doi:10.1186/1742-4755-11-80
Cite this article as: Woldu et al.: The prevalence of Group B Streptococus
recto-vaginal colonization and antimicrobial susceptibility pattern in
pregnant mothers at two hospitals of Addis Ababa, Ethiopia. Reproductive
Health 2014 11:80.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
